Applied Biochemistry and Biotechnology 2024

3 papers
In 2024, research published in Applied Biochemistry and Biotechnology addressed diverse challenges across environmental microbiology, computational drug discovery, and molecular oncology. A prominent theme involved the investigation of biological systems for industrial and therapeutic applications. This included the study of microbial symbionts, such as Stenotrophomonas maltophilia isolated from the gut of plastic-eating Tenebrio molitor larvae, which explores biological mechanisms for plastic degradation. The year's contributions also emphasized advanced computational and molecular techniques in cancer research. One study utilized QSAR modeling and molecular dynamics simulations to identify novel PI3Kα inhibitors for gastric cancer treatment. Another investigation focused on the regulatory role of miR-328-3p in prostate cancer, specifically its ability to inhibit epithelial-mesenchymal transition by downregulating PFN1. Prolific authors contributing to these developments included Dongfang Li, Li Guo, Shasha Ye, and Jian Chen. These works reflect a trend toward integrating bioinformatic analysis with experimental validation to address complex biochemical processes.

Papers

Title
Identification of Novel PI3Kα Inhibitor Against Gastric Cancer: QSAR-, Molecular Docking–, and Molecular Dynamics Simulation–Based Analysis
Overexpression of miR-328-3p Inhibits Epithelial-Mesenchymal Transition in Prostate Cancer by Downregulating PFN1
Stenotrophomonas maltophilia Isolated from the Gut Symbiotic Community of the Plastic-Eating Tenebrio molitor